Bowel (colorectal) cancer, Colon cancer
Open
Phase 2
This trial is looking at having dostarlimab before and after surgery for bowel cancer.
It is for people who:
have bowel cancer that has spread into the surrounding tissues
can have surgery to remove their cancer
are older, frail or both
Recruitment start: 29 November 2024
Recruitment end: 30 November 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jenny Seligmann
University of Leeds
GlaxoSmithKline (GSK)
National Institute for Health Research (NIHR)
Last reviewed: 03 Sept 2026
CRUK internal database number: 20074